Meta-analysis
~9% lower mortality per 1,000 additional steps/day in 2024 meta-analysis; nonlinear benefit
Cohort study
Large cohort: ~6% lower mortality per 1-point increase in overall life satisfaction score (HR ~0.94)
Meta-analysis
LDL-C ≥160 mg/dL associated with higher all-cause mortality (RR 1.34, 95% CI 1.00–1.80) and CVD death (RR 1.79, 95% CI 1.26–2.54) vs LDL-C 70–129 mg/dL, in a meta-analysis of 1,232,694 adults
Observational study
Older-adult cohort: negative relationship quality OR 1.20 over 5 years; criticism OR 1.44
Meta-analysis
Vs BMI 22.5–<25: obesity 30–<35 HR 1.45; 35–<40 HR 1.94; 40–<60 HR 2.76
Global BMI Mortality Collaboration · Lancet · 2016 · PMID 27423262
Read the study →
Observational study
Highest vs lowest activity roughly 25–35% lower mortality in major prospective meta-analyses
Cohort study
Never smoker = reference; current smoking ~2.18–2.81× mortality in large cohorts; former smokers can approach never-smoker risk after prolonged cessation
Observational study
In nondiabetic adults, glycated hemoglobin showed a J-shaped association with death from any cause, remaining significant after adjustment for fasting glucose, in the ARIC cohort (n=11,092)
Moderate for defined job strain; limited for generic stress
Cohort study
Job strain meta-analysis: CHD RR ~1.26; multicohort mortality HR 1.68 in men with cardiometabolic disease